Literature DB >> 7613431

Recent advances. Psychiatry.

R Ramsay1, T Fahy.   

Abstract

Mesh:

Year:  1995        PMID: 7613431      PMCID: PMC2550225          DOI: 10.1136/bmj.311.6998.167

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  35 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

Review 2.  Toward a neuroanatomy of obsessive-compulsive disorder.

Authors:  T R Insel
Journal:  Arch Gen Psychiatry       Date:  1992-09

3.  Dopamine D4 receptor subtypes and response to clozapine.

Authors:  S Shaikh; D Collier; R W Kerwin; L S Pilowsky; M Gill; W M Xu; A Thornton
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

4.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

5.  Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

Authors:  L Farde; A L Nordström; F A Wiesel; S Pauli; C Halldin; G Sedvall
Journal:  Arch Gen Psychiatry       Date:  1992-07

6.  Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.

Authors:  L S Pilowsky; D C Costa; P J Ell; R M Murray; N P Verhoeff; R W Kerwin
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

7.  Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

Authors:  C L Katona; M T Abou-Saleh; D A Harrison; B A Nairac; D R Edwards; T Lock; R A Burns; M M Robertson
Journal:  Br J Psychiatry       Date:  1995-01       Impact factor: 9.319

8.  Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.

Authors:  R T Rubin; J Villanueva-Meyer; J Ananth; P G Trajmar; I Mena
Journal:  Arch Gen Psychiatry       Date:  1992-09

9.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.

Authors:  L R Baxter; J M Schwartz; K S Bergman; M P Szuba; B H Guze; J C Mazziotta; A Alazraki; C E Selin; H K Ferng; P Munford
Journal:  Arch Gen Psychiatry       Date:  1992-09

10.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

Authors:  S E Swedo; P Pietrini; H L Leonard; M B Schapiro; D C Rettew; E L Goldberger; S I Rapoport; J L Rapoport; C L Grady
Journal:  Arch Gen Psychiatry       Date:  1992-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.